N@N

Robyn Karnauskas Maintained (AMGN) at Hold with Decreased Target to $260 on, Feb 13th, 2023

Robyn Karnauskas of Truist Securities, Maintained "Amgen Inc." (AMGN) at Hold with Decreased Target from $280 to $260 on, Feb 13th, 2023.

Robyn has made no other calls on AMGN in the last 4 months.

There are 10 other peers that have a rating on AMGN. Out of the 10 peers that are also analyzing AMGN, 4 agree with Robyn's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• David Risinger of "SVB Leerink" Maintained at Hold with Decreased Target to $267 on, Thursday, February 2nd, 2023
• Evan David Seigerman of "BMO Capital" Maintained at Hold with Decreased Target to $253 on, Wednesday, February 1st, 2023
• Gregory Renza of "RBC Capital" Maintained at Hold with Decreased Target to $258 on, Wednesday, February 1st, 2023
• Mohit Bansal of "Wells Fargo" Maintained at Hold with Decreased Target to $275 on, Wednesday, February 1st, 2023

These are the ratings of the 6 analyists that currently disagree with Robyn

---

• Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $294 on, Wednesday, February 1st, 2023
• Carter Gould of "Barclays" Maintained at Sell with Decreased Target to $230 on, Wednesday, February 1st, 2023
• Trung Huynh of "Credit Suisse" Maintained at Sell with Decreased Target to $220 on, Wednesday, February 1st, 2023
• Yaron Weber of "Cowen & Co." Maintained at Buy with Decreased Target to $289 on, Wednesday, February 1st, 2023
• Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $293 on, Thursday, January 19th, 2023
• Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $282 on, Friday, November 4th, 2022

Contributing Sources

---